Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) < x ULN; for the purposes of this study, ULN for SGPT (ALT) is Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< . x the institutional ULN Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< x ULN Alanine aminotransferase (ALT, serum glutamate pyruvate transaminase [SGPT]) =< . x ULN, must be obtained within weeks prior to screening for protocol therapy Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< x ULN even in patients with documented hepatic involvement with lymphoma Serum glutamate pyruvate aminotransferase (SGPT) alanine transferase (ALT) =< . x ULN, within days of registration Obtained within days prior to registration: Serum glutamate pyruvate transaminase (SGPT) alanine aminotransferase (ALT) =< . x ULN Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L Alanine aminotransferase (AST) (serum glutamate pyruvate transaminase [SGPT]): - U/L Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) < . x ULN Within days of randomization: Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< . x ULN Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L. Within days prior to treatment start: Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< . x ULN Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< x ULN\r\n* Temozolomide should not be administered if total bilirubin is > . mg/dl or SGPT(ALT) > . x ULN Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]): =< x the ULN Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]): =< x the ULN Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< . x ULN, or =< x ULN in patients with documented liver metastases within days of cycle day Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L within days of registration Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< . x institutional ULN Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< x ULN for age Alanine aminotransferase (ALT) serum glutamate pyruvate transaminase (SGPT) < . x ULN Alanine aminotransferase (ALT) serum glutamate pyruvate transaminase (SGPT) =< . x ULN OR =< x ULN for subjects with liver metastases Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) < Alanine transferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< . X ULN Serum glutamate pyruvate transaminase (SGPT) < . x ULN Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< X institutional ULN Aspartate transaminase (AST) and alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< x ULN unless evidence of the direct liver and/or bone involvement by lymphoma, then =< x ULN, obtained =< days prior to registration Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) concentration < x the ULN; patients with metastatic liver disease are eligible if SGPT (ALT) is < x the ULN Alanine aminotransferase (ALT)/serum glutamic pyruvate transaminase (SGPT) =< . x ULN For Part A participants: serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) concentration =< x the institutional ULN Serum glutamate pyruvate transaminase (SGPT) alanine aminotransferase (ALT) < x institutional normal Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< x ULN Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]): =< x the ULN Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< x ULN Alanine aminotransferase (ALT)/serum glutamate pyruvate transaminase (SGPT) =< x UNL (=< x ULN if liver metastases present) obtained =< weeks prior to enrollment Serum glutamate pyruvate transaminase (SGPT) =< IU/ml unless related to patient malignancy Alanine aminotransferase (ALT, serum glutamate pyruvate transaminase [SGPT]) =< . x ULN Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) < x institutional normal Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< . x ULN for age Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< . X ULN Serum glutamate-pyruvate transaminase (SGPT) =< . ULN (=< . ULN with liver metastasis) Serum glutamate pyruvate transaminase (SGPT) alanine transferase (ALT) < x institutional normal Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< . x ULN for age Alanine aminotransferase (ALT, serum glutamate pyruvate transaminase [SGPT]) =< . x ULN (=< . x ULN in patients with known liver metastases) Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< X institutional ULN Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) < . X ULN Within days prior to study registration: Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< U/L Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< . x institutional ULN Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< x ULN Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< . X ULN Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< x ULN for age, unless elevation due to leukemic infiltration Serum glutamic pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< . times institutional ULN for age Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< . X institutional ULN Serum glutamate pyruvate transaminase (SGPT) =< IU/ml (unless Gilbert's syndrome) Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< x IULN except when in the opinion of treating physician is due to direct involvement of leukemia (e.g. hepatic infiltration or biliary obstruction due to leukemia) or Gilbert's disease Alanine aminotransaminase (ALT, serum glutamate pyruvate transaminase [SGPT]) =< . x ULN Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< X ULN Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< x ULN Alanine aminotransferase (ALT, serum glutamate pyruvate transaminase [SGPT]) =< . x ULN Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) < Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< . x ULN Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) < Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< . x ULN Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< x ULN Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< X ULN; exception for patients with liver metastasis: ALT (SGPT) =< X ULN Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< x ULN Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< . x ULN Alanine aminotransferase (ALT) =< x ULN (serum glutamate pyruvate transaminase [SGPT]) Serum glutamate pyruvate transaminase (SGPT) =< IU/mL Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) concentration < X the institutional ULN Serum glutamate pyruvate transaminase (SGPT) < . x ULN Serum glutamate pyruvate transaminase (SGPT) < IU/L unless related to patient's malignancy Alanine aminotransferase (ALT, serum glutamate pyruvate transaminase [SGPT]) =< . x ULN Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< X ULN Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< x ULN; in patients with significant liver disease and chronically elevated liver transaminases, ALT may be elevated as high as x ULN Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< . x ULN for age Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< x normal Alanine aminotransferase (ALT, serum glutamate pyruvate transaminase [SGPT]) =< ULN Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) < . x ULN Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< . institutional ULN Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< . x institutional ULN obtained =< days prior to randomization Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< . x ULN, obtained within days prior to treatment start Serum glutamate pyruvate transaminase (SGPT) < . x ULN Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< . x ULN OR =< x ULN for subjects with liver metastases, performed within days of treatment initiation Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) < x ULN